13.04.2018 • News

Kemira Expands Chlor-alkali Capacity

Kemira Expands Chlor-alkali Capacity
Kemira Expands Chlor-alkali Capacity

Kemira has announced plans to invest a multi-million euro sum to expand production of chlor-alkali at its site in Joutseno, Finland. The additional capacity is expected to be operational during the fourth quarter of 2018 and will, said Kemira, meet the country’s growing need for caustic soda

Capacity details were not revealed although industry association Euro Chlor lists the plant as producing 75,000 t/y of chlorine. The Joutseno site produces caustic soda, hydrochloric acid and sodium hypochlorite for the pulp and paper and process industries as well as for municipal water treatment.

Last September, Kemira finalized a €50 million investment in a new sodium chlorate production line at Joutseno. The line is based on Kemira’s proprietary in-house technology.

Kemira said demand for bleaching chemicals is increasing as a result of pulp mill expansions and greenfield projects in the Nordics. Sodium chlorate is the raw material for chlorine dioxide, which is produced on-site at the pulp mills and is the primary bleaching agent for kraft pulp.

In separate news, Kemira has signed a multi-year agreement to supply Chevron North Sea with high-quality polymer (polyacrylamides) for Chemical Enhanced Oil Recovery (CEOR). Kemira had previously instigated an expansion of its polyacrylamides capacity in Botlek, the Netherlands, to service the agreement.

The project is costing around €30 million, and the additional capacity is expected to be commercially available by the beginning of 2019.

 

Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.